论文部分内容阅读
目的:对普米克令舒联合万托林雾化吸入治疗毛细支气管炎的疗效及该治疗方法的可行性提供理论基础与参考依据。方法:将我院2013年6月~2013年12月接诊的68例毛细支气管炎患儿作为研究对象,随机将患儿分为对照组与观察组。对照组34例患儿通过雾化吸入万托林的方式进行治疗,观察组34例患儿使用普米克令舒联合万托林雾化吸入的方式进行治疗。结果:相较于对照组,观察组患儿临床症状消失时间更快,治疗总有效率更高,不良反应发生率更低,两组对比差异显著(P<0.05),具有统计学意义。结论:毛细支气管炎行普米克令舒联合万托林雾化吸入治疗,能快速缓解病情,增强治疗效果,降低不良反应发生率,安全性能高,能促进患儿尽早康复,适合于临床推广应用。
OBJECTIVE: To provide the theoretical basis and reference basis for the efficacy of Pulmicort Respules combined with Vanthorine inhalation for the treatment of bronchiolitis and the feasibility of the treatment. Methods: A total of 68 patients with bronchiolitis admitted from June 2013 to December 2013 in our hospital were randomly divided into control group and observation group. Thirty-four children in the control group were treated with inhalation of vetindol by inhalation. 34 children in the observation group were treated with inhalation of pulmicort and vancomycin. Results: Compared with the control group, the clinical symptoms in the observation group disappeared faster, the total effective rate was higher and the incidence of adverse reactions was lower. The difference between the two groups was significant (P <0.05), which was statistically significant. Conclusion: Bronchitis patients treated with pulmicort respules combined with WanTuoLing atomized inhalation can quickly relieve the illness, enhance the curative effect, reduce the incidence of adverse reactions, and have high safety performance, which can promote the early rehabilitation of children and is suitable for clinical popularization and application .